CNE100003449
CNE100003449
BGI GENOMICS
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 19.02B EUR | 14.67B EUR | 16.67B EUR | 18.97B EUR |
Enterprise Value | 16.62B EUR | 12.5B EUR | 14.32B EUR | 16.33B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | 284.19x | -- | -- | -- |
Price to Sales | 4.93x | 5.2x | 5.95x | 7.12x |
Price to Book | 2.25x | 1.72x | 1.98x | 2.23x |
EV/Revenue | 4.3x | 4.43x | 5.11x | 6.13x |
EV/EBITDA | -395.41x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -1.86% | -2.53% | -1.86% | -2.76% |